A Best Practice Approach to Developing & Managing an Injection Clinic: Changing Pharma Options Brings New Interest in Injectable Medications

OPEN MINDS The Behavioral Health & Social Service Industry Analyst Industry Special Injection clinics as a service delivery option for delivery of long-acting antipsychotic medications have been in operation since the introduction of the first generation antipsychotics in the 1960s (fluphenazine enanthate in 1963, fluphenazine decanoate in 1967, and haloperidol decanoate in 1986). First generation long-acting antipsychotic medications were specifically developed as maintenance treatment for patients with a history of nonadherence with oral antipsychotics. By simplifying the medication process—no more need to take pills every day—the ability to monitor medication adherence made treatment more manageable for . . .